Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.08.29
关于召开2018年第四次暂时股东大会的通知通告
2018.08.29
关于变换深圳君圣泰生物手艺有限公司股权架构调解计划的通告
2018.08.29
关于向招商银行申请并购贷款暨接受关联方担保的通告
2018.08.29
2018年半年度召募资金存放与使用情形的专项报告
2018.08.29
第四届董事会第十六次聚会决议通告
2018.08.29
2018年半年度财务报告
2018.08.15
关于控股子公司取得产品授权暨对控股子公司增资的通告
2018.07.31
2018年半年度业绩快报
2018.07.27
2018年第三次暂时股东大会决议通告
2018.07.27
2018年第三次暂时股东大会的执法意见书
第一页
上一页
50
51
52
53
54
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】